ストックスクリーナーアプリを入手
85.43
0.60%
0.51
アフターアワーズ：
85.43
前日終値:
$84.92
開ける：
$85.25
24時間の取引高:
561.30K
Relative Volume:
0.94
時価総額：
$4.29B
収益：
$1.33B
当期純損益:
$114.89M
株価収益率:
34.31
EPS:
2.49
ネットキャッシュフロー:
$70.97M
1週間 パフォーマンス:
-5.86%
1か月 パフォーマンス:
+14.10%
6か月 パフォーマンス:
-8.33%
1年 パフォーマンス:
+3.61%
1日の値動き範囲:
$84.42
$86.68
1週間の範囲:
$83.32
$91.43
52週間の値動き範囲:
$70.25
$97.97
Haemonetics Corp Stock (HAE) Company Profile
HAE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| HAE | 85.43 | 4.29B | 1.33B | 114.89M | 70.97M | 2.49 |
| ISRG | 550.62 | 194.93B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 225.45 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.57 | 42.36B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 243.60 | 35.51B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 320.88 | 22.81B | 2.88B | 499.60M | 321.60M | 7.41 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-01-27 | ダウングレード | Needham | Buy → Hold |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-08-17 | 再開されました | Raymond James | Outperform |
| 2021-06-17 | 開始されました | Citigroup | Buy |
| 2021-05-14 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 開始されました | Needham | Buy |
| 2019-08-07 | 繰り返されました | Barrington Research | Outperform |
| 2019-05-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 繰り返されました | Barrington Research | Outperform |
| 2018-08-09 | 繰り返されました | Barrington Research | Outperform |
| 2018-02-07 | 繰り返されました | Barrington Research | Outperform |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 繰り返されました | Barrington Research | Outperform |
| 2017-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 繰り返されました | The Benchmark Company | Hold |
| 2016-09-20 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-08-02 | 繰り返されました | Jefferies | Buy |
| 2016-08-02 | 繰り返されました | The Benchmark Company | Hold |
すべてを表示
Haemonetics Corp (HAE) 最新ニュース
Haemonetics Co. (NYSE:HAE) Shares Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Leukapheresis Market 2024 Opportunity, Challenge, Drivers, - openPR
[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
Haemonetics Co. (NYSE:HAE) Holdings Increased by Thrivent Financial for Lutherans - MarketBeat
Principal Financial Group Inc. Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Given Buy Rating at Needham & Company LLC - MarketBeat
Royce & Associates LP Has $97.30 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Aigen Investment Management LP Makes New Investment in Haemonetics Co. (NYSE:HAE) - MarketBeat
T. Rowe Price Investment Management, Inc. Expands Stake in Haemo - GuruFocus.com
Capital Research Global Investors Adjusts Stake in Haemonetics C - GuruFocus.com
Here's Why Haemonetics (HAE) is a Strong Value Stock - Yahoo Finance
Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet - Yahoo Finance
Haemonetics Corporation (NYSE:HAE) Q2 2025 Earnings Call Transcript - Insider Monkey
Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand - Yahoo Finance
Barrington Research Reaffirms Outperform Rating for Haemonetics (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Creative Planning Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE) - Defense World
Raymond James Upgrades Haemonetics (HAE) - MSN
Raymond James upgrades haemonetics stock, highlights overlooked growth drivers - Investing.com
Wellington Management Group LLP Increases Stake in Haemonetics C - GuruFocus.com
Haemonetics (NYSE:HAE) Raised to Strong-Buy at Raymond James - MarketBeat
Deep Dive Into Haemonetics Stock: Analyst Perspectives (7 Ratings) - Benzinga
Haemonetics: Fiscal Q2 Earnings Snapshot - Houston Chronicle
Haemonetics earnings beat by $0.05, revenue topped estimates - Investing.com
Haemonetics (NYSE:HAE) Shares Gap UpStill a Buy? - MarketBeat
Haemonetics Corp (HAE) Shares Up 10.58% on Nov 7 - GuruFocus.com
Haemonetics (HAE) Shares Cross Above 200 DMA - Nasdaq
Haemonetics (NYSE:HAE) Issues FY25 Earnings Guidance - MarketBeat
Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics - Yahoo Canada Finance
Haemonetics Corp Q2 FY2025 Earnings: Revenue Hits $345.5M, EPS a - GuruFocus.com
Haemonetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 28, 2024 - Marketscreener.com
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Quantisnow
Haemonetics Corp (HAE) Q2 2025 Earnings Report Preview: What To Expect - GuruFocus.com
Harbor Capital Advisors Inc. Acquires 30,389 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
F M Investments LLC Purchases New Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Assenagon Asset Management S.A. Cuts Stock Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Haemonetics stock hits 52-week low at $70.5 amid challenges - Investing.com
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Haemonetics (HAE) to Release Quarterly Earnings on Thursday - MarketBeat
Haemonetics (HAE) Set to Announce Quarterly Earnings on Thursday - Defense World
Boston Trust Walden Corp Increases Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Riverwater Partners LLC Acquires 29,109 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Creative Planning Makes New Investment in Haemonetics Co. (NYSE:HAE) - Defense World
Potential Price Increase for Haemonetics Corp. (HAE) After Recent Insider Activity - Knox Daily
Northwestern Mutual Wealth Management Co. Sells 161 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Are Haemonetics Corp. (HAE) shares a good deal now? - US Post News
Balance Sheet Dive: Haemonetics Corp. (HAE)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Blood Collection Devices Global Market 2024, with Profiles of Abbott, Becton, Dickinson, FL Medical, Fresenius, Greiner Bio-One, Haemonetics, Medtronic, Nipro Medical, Qiagen, Sarstedt & Terumo BCT - Yahoo Finance
Haemonetics Corp (HAE) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Q2 2025 EPS Estimates for Haemonetics Co. (NYSE:HAE) Cut by Analyst - MarketBeat
Haemonetics Corp (HAE) 財務データ
収益
当期純利益
現金流量
EPS
1.09%
大文字化:
|
ボリューム (24 時間):